XML 150 R138.htm IDEA: XBRL DOCUMENT v3.23.1
Equity settled share-based transactions - Restricted Share Scheme (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
item
$ / shares
Jun. 30, 2022
USD ($)
item
$ / shares
May 18, 2022
USD ($)
item
$ / shares
Aug. 01, 2017
item
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted         3,537,409  
Equity-settled share-based payment expenses           $ 532,752
Restricted shares            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted | item       5,313,900    
Subscription price | $ / shares       $ 0.01    
Aggregate fair value of the restricted shares granted $ 5,799,625       $ 5,799,625  
Aggregate fair value of the restricted shares granted (in Dollar per share) | $ / shares         $ 1.091  
Equity-settled share-based payment expenses         $ 15,534  
Restricted Share Units            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted           3,996,997
PHCL 2022 Plan [Member] | Restricted shares            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Equity-settled share-based payment expenses         $ 7,732,961  
PHCL 2022 Plan [Member] | Restricted Share Units | Third parties            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted | item   2,446,557        
PHCL 2022 Plan [Member] | Restricted Share Units | Directors            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted | item 946,330          
PHCL 2022 Plan [Member] | Restricted Share Units | Employees            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Number of restricted shares granted | item     144,522      
Ifrs Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 2 $ 4.04 $ 7.64      
Weighted average fair value of other equity instruments granted in share-based payment arrangement, Value $ 1,892,660 $ 9,884,090 $ 1,104,148      
Bottom of range [member]            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Percentage of trade sale defined in share agreement       50.00%    
First anniversary | Restricted shares            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Vesting percentage       33.33%    
Twenty three months | Restricted shares            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Monthly vesting percentage       2.77%    
Third anniversary | Restricted shares            
Disclosure of terms and conditions of share-based payment arrangement [line items]            
Monthly vesting percentage       2.96%